As a reader of m6A, IGF2BP2 is associated with carcinogenesis, and has been tested to be associated with the occurrence and prognosis of various cancers including colorectal cancer [55], gastrointestinal cancer [56], endometrial cancer [57], pancreas cancer [58], breast cancer [59] and Head and Neck Squamous Cell Carcinoma [60]. This evidence concerns the gene IGF2BP2 and breast carcinoma.